AMD and the alternative complement pathway: genetics and functional implications

AMD and the alternative complement pathway: genetics and functional implications

Item
http://www.wikidata.org/entity/Q26744106
Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors.Protective Effect of Met12, a Small Peptide Inhibitor of Fas, on the Retinal Pigment Epithelium and Photoreceptor After Sodium Iodate InjuryNovel evidence for complement system activation in chick myopia and hyperopia models: a meta-analysis of transcriptome datasets.Investigation of associations of ARMS2, CD14, and TLR4 gene polymorphisms with wet age-related macular degeneration in a Greek population.Autophagy regulates death of retinal pigment epithelium cells in age-related macular degenerationNicotinamide, iRPE-in-a dish, and age-related macular degeneration therapy development.Current drug and molecular therapies for the treatment of atrophic age-related macular degeneration: phase I to phase III clinical development.Delivery of CR2-fH Using AAV Vector Therapy as Treatment Strategy in the Mouse Model of Choroidal Neovascularization.Effect of Anti-C5a Therapy in a Murine Model of Early/Intermediate Dry Age-Related Macular Degeneration.Genes and genetics in eye diseases: a genomic medicine approach for investigating hereditary and inflammatory ocular disorders.A2E-associated cell death and inflammation in retinal pigmented epithelial cells from human induced pluripotent stem cells.Dysfunction of cGMP signalling in photoreceptors by a macular dystrophy-related mutation in the calcium sensor GCAP1.Encapsulated Cell Technology-Based Delivery of a Complement Inhibitor Reduces Choroidal Neovascularization in a Mouse Model.The C3dg Fragment of Complement Is Superior to Conventional C3 as a Diagnostic Biomarker in Systemic Lupus Erythematosus.A monoclonal antibody targeting amyloid β (Aβ) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and Alzheimer's disease.Subretinal macrophages produce classical complement activator C1q leading to the progression of focal retinal degeneration
P2860

AMD and the alternative complement pathway: genetics and functional implications

Item
http://www.wikidata.org/entity/Q26744106
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
AMD and the alternative complement pathway: genetics and functional implications
@ast
AMD and the alternative complement pathway: genetics and functional implications
@en
AMD and the alternative complement pathway: genetics and functional implications
@nl
type
label
AMD and the alternative complement pathway: genetics and functional implications
@ast
AMD and the alternative complement pathway: genetics and functional implications
@en
AMD and the alternative complement pathway: genetics and functional implications
@nl
prefLabel
AMD and the alternative complement pathway: genetics and functional implications
@ast
AMD and the alternative complement pathway: genetics and functional implications
@en
AMD and the alternative complement pathway: genetics and functional implications
@nl
P1433
P1476
P2093
P275
P2860
P2888
P304
P31
P3181
P356
P407
P433
P478
P50
P5008
P577
P6179
P698
P921
P932
P3181
P356
P1433
P1476
AMD and the alternative complement pathway: genetics and functional implications
@en
P2093
P275
P2860
P2888
P304
P31
P3181
P356
P407
P433
P478
P50
P5008
P577
P6179
P698
P921
P932